Contact this trialFirst, we need to learn more about you.
Radioisotope Therapy
AlphaMedix for Neuroendocrine Cancer
Recruiting1 awardPhase 2
Metairie, Louisiana
This trial tests a radioactive drug called 212Pb-DOTAMTATE in adults with neuroendocrine tumors. It aims to see how well it works in patients who are either new to or have previously received similar treatments. The drug targets and kills cancer cells using radiation.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service